Press release
Rising Prevalence Of Alzheimer's Disease To Drive Market Growth: A Key Driver Powering Alzheimer's Drugs Market Growth In 2025
Alzheimer's Drugs
What Is the Current Alzheimer's Drugs Market Size and Its Estimated Growth Rate?
The market size for Alzheimer's medication has seen robust expansion in the past few years. Forecasts predict an increase from $9.33 billion in 2024 to $10.19 billion by 2025, marking a compound annual growth rate (CAGR) of 9.1%. The growth witnessed in the historical period can be tied to an uptick in Alzheimer's disease cases, sustained funding in scientific investigation and development, a deeper comprehension of disease mechanisms, internationally coordinated health programs, and increased public awareness and education.
The market size for Alzheimer's medications is projected to experience robust growth over the next few years, increasing to approximately $14.47 billion in 2029 with a compound annual growth rate (CAGR) of around 9.2%. This predicted growth during the forecast period can be connected to the adoption of precision medicine approaches, attention given to disease modification, the identification and validation of biomarkers, patient-centric drug design, and the focus on non-pharmaceutical interventions. Major market trends for the forecast period include varied therapeutic tactics, digital health tools, regenerative medicine, breakthroughs in diagnostic technologies, the use of artificial intelligence (AI) in the development of new medications, and strategic partnerships and collaborations.
Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9040
How Are Emerging Segments Shaping the Alzheimer's Drugs Market Landscape?
The alzheimer's drugs market covered in this report is segmented -
1) By Drugs: Donepezil, Rivastigmine, Galantamine, Memantine
2) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy
3) By Application: Early To Moderate Stages, Moderate To Severe Stages
Subsegments:
1) By Donepezil: Oral Tablets, Oral Solution
2) By Rivastigmine: Oral Capsules, Oral Solution, Transdermal Patches
3) By Galantamine: Oral Tablets, Oral Solution, Extended-Release Capsules
4) By Memantine: Oral Tablets, Oral Solution, Extended-Release Capsules
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9040&type=smp
Which Growth Factors Are Influencing Alzheimer's Drugs Market Expansion?
The anticipated escalation in cases of Alzheimer's disease is likely to drive the Alzheimer's drugs market's growth. Alzheimer's disease, a progressive neurological disorder, leads to shrinkage of the brain and cell death over time. Drugs designed to treat Alzheimer's focus on addressing memory loss, difficulty with cognitive processes, and the challenges of day-to-day living. Such Alzheimer's drugs can significantly improve patients' quality of life and help them maintain their independence. For example, a report by the Alzheimer's Association, a US nonprofit organization in Alzheimer's care, support, and research, in May 2024 revealed an increase in Alzheimer's dementia cases among Americans aged 65 and above from 6.5 million in 2022 to a projected 6.9 million in 2024. Consequently, the rising incidence of Alzheimer's is fueling the expansion of the Alzheimer's drugs market.
Who Are the Dominant Players Across Different Alzheimer's Drugs Market Segments?
Major companies operating in the alzheimer's drugs market include AbbVie Inc., Daiichi Sankyo Company Limited, F Hoffmann-La Roche AG, Merck & Co Inc., Novartis AG, Biogen Inc., AstraZeneca PLC, Eisai Co Ltd., Eli Lilly and Company, H Lundbeck A/S, Pfizer Inc., Allergan PLC., Johnson & Johnson, Lupin Pharmaceuticals Inc., Actiza Pharmaceutical Private Limited, Neurotrope Inc., AC Immune SA, Adamas Pharmaceuticals Inc, Alzheon Inc., Anavex Life Sciences Corp, Axsome Therapeutics Inc., Cassava Sciences Inc., Cognition Therapeutics Inc., Cortexyme Inc., Denali Therapeutics Inc, EIP Pharma Inc., Enlivex Therapeutics Ltd., FORUM Pharmaceuticals Inc., Genentech Inc., Green Valley Pharmaceuticals LLC, Intra-Cellular Therapies Inc., Karuna Therapeutics Inc., Neurim Pharmaceuticals Ltd
What Are the Latest Developing Trends in the Alzheimer's Drugs Market?
Leading firms in the Alzheimer's drugs industry are concentrating on the creation of novel products, such as therapies that target amyloid plaque, to improve treatments and patient recovery. The amyloid plaque-targeting therapy is a treatment strategy for Alzheimer's disease that aims to decrease or inhibit the buildup of amyloid-beta plaques in the brain. For example, in June 2024, Eli Lilly and Company, a pharmaceutical company based in the US, received the approval for Kisunla (donanemab-azbt) from the Food and Drug Administration (FDA), the US federal agency responsible for public health protection. Kisunla (donanemab-azbt) stands out as the first and only treatment focusing on amyloid plaque for the early symptomatic phase of Alzheimer's disease. It functions by assisting the body in eliminating excess amyloid plaques from the brain connected with cognitive deterioration in Alzheimer's patients. Kisunla is given as an intravenous infusion every four weeks. The initial dose includes 700 mg for the initial three doses, followed by 1400 mg for subsequent doses. Kisunla is specifically recommended for adults with mild cognitive impairment (MCI) and minor Alzheimer's disease dementia stages, only if they have confirmed amyloid pathology.
Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/alzheimers-drugs-global-market-report
Which Geographic Regions Are Expected to Dominate the Alzheimer's Drugs Market in the Coming Years?
North Americawas the largest region in the Alzheimer's drugs market in 2024. Asia-Pacific is expected to be the fastest-growing region in the Alzheimer's drugs market during the forecast period. The regions covered in the Alzheimer's drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Alzheimer's Drugs Market?
2. What is the CAGR expected in the Alzheimer's Drugs Market?
3. What Are the Key Innovations Transforming the Alzheimer's Drugs Industry?
4. Which Region Is Leading the Alzheimer's Drugs Market?
Why This Report Matters:
Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.
Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.
Efficient Research: Quickly identify market growth, leading players, and major segments.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Rising Prevalence Of Alzheimer's Disease To Drive Market Growth: A Key Driver Powering Alzheimer's Drugs Market Growth In 2025 here
News-ID: 3976898 • Views: …
More Releases from The Business Research Company
The Role Of Advanced Driver-Assistance Systems (ADAS) In Autonomous Vehicle Simu …
The Autonomous Vehicle Simulation Solutions Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected Autonomous Vehicle Simulation Solutions Market Size During the Forecast Period?
In recent times, there's been significant growth in the market size of autonomous vehicle simulation solutions. Forecasted expansion shows…
Autonomous Agents Industry Report 2025-2034: Market Dynamics, Trends, And Foreca …
The Autonomous Agents Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected Autonomous Agents Market Size During the Forecast Period?
In the last few years, the market size for autonomous agents has seen an exponential rise. The projection is that its worth will…
Evolving Market Trends In The Automotive Smart Antenna Industry: Transparent Ant …
The Automotive Smart Antenna Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected Automotive Smart Antenna Market Size During the Forecast Period?
Over the years, the market size of the automotive smart antenna has witnessed significant growth. This market is projected to expand…
Automotive Prognostics Market Surges In Response To Road Accident Concerns: Key …
The Automotive Prognostics Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected Automotive Prognostics Market Size During the Forecast Period?
In recent times, the automotive prognostics market has witnessed a significant expansion. The market size, which is at $8.32 billion in 2024, is…
More Releases for Alzheimer
Global Alzheimer Market, Global Alzheimer Industry, Covid-19 Impact Global Alzhe …
Alzheimer's is a progressive disease that leads to the death of brain cells, resulting in memory loss, behavioral issues, and disruption the thought processes. The Alzheimer disease is considered fatal. Age and heredity are the two main risk factors for developing Alzheimer's disease. Several other preventable risk factors have been associated to the development of this disease, including diet, environment, and overall general health. A combination of risk factors is…
Anti-β-Alzheimer Therapies Market : Consumption, Revenue, Applications With Maj …
Alzheimer disease (AD) is a type of dementia that affects memory, thinking, language and behavior. Increasing age and high number of people suffering from Alzheimer's with age 65 and older are the major risk factors for progression of this disorder. It starts with mild symptoms and ends with severe brain damage in which individuals lose the ability to carry on a conversation and respond to their environment. According to Alzheimer…
Anti-β-Alzheimer Therapies That Cut Attacks Hailed As 'huge Deal'
Alzheimer disease (AD) is a type of dementia that affects memory, thinking, language and behavior. Increasing age and high number of people suffering from Alzheimer's with age 65 and older are the major risk factors for progression of this disorder. It starts with mild symptoms and ends with severe brain damage in which individuals lose the ability to carry on a conversation and respond to their environment. According to Alzheimer…
Alzheimer Diagnostic Tests Market - Medical Devices Pipeline Assessment, 2017 | …
"The Latest Research Report Alzheimer Diagnostic Tests - Medical Devices Pipeline Assessment, 2017 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz"
About Alzheimer Diagnostic Tests Market
GlobalData's Medical Devices sector report, Alzheimer Diagnostic Tests - Medical Devices Pipeline Assessment, 2017" provides an overview of Alzheimer Diagnostic Tests currently in pipeline stage.
The report provides comprehensive information on the pipeline products with comparative analysis of…
US Alzheimer Drug Pipeline Analysis
In US, the Alzheimer's disease is the 6th leading cause of death overall and among those aged 65 and above, it is the 5th leading cause of death. While the deaths from major diseases, like heart disease have decreased, the death due to Alzheimer's have increased by more than 60% between 2000 and 2012. The total number of patients having Alzheimer’s disease was 5.4 million in 2012. Out of this,…
Global Alzheimer Market Report: 2015 Edition | Now Available at Researchmoz.us
Researchmoz added Most up-to-date research on "Global Alzheimer Market Report: 2015 Edition" to its huge collection of research reports.
Alzheimer’s disease is defined as an advanced neurological disorder that increasingly deprives patients of their memory and ability to carry out daily activities. As it grows in a human brain, individuals are likely to practice difficulties in linguistic, agility and insight along with negative changes in the character and performance such as…
